Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018.

Josanne S de MaarMarianne LuyendijkBritt B M SuelmannDave E W van der KruijssenSjoerd G EliasSabine SieslingElsken van der Wall

Published in: Breast cancer research and treatment (2023)

Differences in clinicopathological characteristics and survival between de novo and metachronous metastatic breast cancer highlight that these are distinct patients groups.

Keyphrases

metastatic breast cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
patient reported outcomes